Borrelia miyamotoi disease

Usually a nonspecific acute fever—sometimes literally relapsing

Common symptoms include high fever, chills, marked fatigue, headache, muscle pain, joint pain and nausea. Leukopenia, thrombocytopenia and elevated liver enzymes can occur. Unlike Lyme disease, a classic erythema migrans rash is uncommon. Some patients experience an initial febrile episode followed by improvement and then another episode—hence the relapsing-fever classification.

Severe neurologic disease is uncommon but has been reported, particularly meningoencephalitis in older or immunocompromised patients. Confusion, gait disturbance, hearing changes or other neurologic findings after relevant tick exposure warrant medical evaluation.

Antibiotic treatment is based on case series and relapsing-fever experience.

There are no large prospective randomized treatment trials for B. miyamotoi. Published case series and reviews report clinical response to antibiotics also used for Lyme disease and other Borrelia infections, including doxycycline for uncomplicated disease and intravenous beta-lactam therapy such as ceftriaxone for meningoencephalitis in appropriate clinical settings. A Jarisch–Herxheimer reaction—an acute inflammatory reaction after starting effective therapy—can occur.

The evidence base is therefore less mature than it is for Lyme disease, but it is still far stronger than an untested herbal protocol.

Antigenic variation lets the spirochete repeatedly escape antibody pressure.

Relapsing-fever Borrelia can alter major surface antigens while infection is underway. The immune system clears the dominant antigenic population, fever falls, and a variant population that is less well recognized can expand—producing another episode. That antigenic-switching biology is one reason B. miyamotoi belongs conceptually with relapsing-fever organisms even though it is carried by hard ticks.

Not every patient actually experiences multiple relapses. In the largest North American series summarized in the 2023 review, relapsing fever was less common than the name might imply, possibly because patients received antibiotics before repeated cycles could develop.

How exposure differs from Lyme disease

Lyme Borrelia are not efficiently passed from an infected female Ixodes tick into her eggs. B. miyamotoi, by contrast, can be transmitted transovarially. That means larvae may already be infected before their first blood meal. This difference changes the ecology and means rules of thumb about Lyme transmission should not automatically be copied to B. miyamotoi.

Laboratory patterns

During acute illness, leukopenia, thrombocytopenia and elevated liver enzymes can occur, creating overlap with anaplasmosis and ehrlichiosis. Because B. miyamotoi can reach comparatively high concentrations in blood, spirochetes can sometimes be visible on stained peripheral smears, something that is generally not useful for ordinary Lyme disease.

What about a “Lyme-negative” febrile illness?

A patient with fever, chills, headache and myalgia after Ixodes exposure who lacks an erythema migrans rash and has negative or inconclusive Lyme testing may still have another tick-borne infection. B. miyamotoi, anaplasmosis and babesiosis are among the organisms clinicians may consider depending on geography, timing and laboratory findings.

Jarisch–Herxheimer reaction

Like other spirochetal infections, treatment can trigger an acute cytokine-mediated reaction shortly after effective antibiotics are started. Fever, chills, tachycardia and transient worsening can occur. It is a recognized treatment-associated phenomenon, not proof that progressively worsening symptoms should simply be ignored.